| Michael Birau, DPM | |
|
1601 N Belt Line Rd Ste A, Mesquite, TX 75149-1791 | |
| (972) 288-7441 | |
| (833) 916-2197 |
| Full Name | Michael Birau |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 7 Years |
| Location | 1601 N Belt Line Rd Ste A, Mesquite, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043743800 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 3074 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor Scott And White Medical Center Sunnyvale | Sunnyvale, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Interventional Partners Pllc | 6800173204 | 80 |
News Archive
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the Food and Drug Administration (FDA) has accepted for filing and designated for Priority Review the Company's New Drug Application (NDA) for rifaximin tablets 550 mg for the maintenance of remission of hepatic encephalopathy (HE). Additionally, the FDA has informed the Company of its plan to schedule an Advisory Committee meeting in late February 2010 to discuss the application.
"Seeing a child die from pneumonia, diarrhea or a mosquito bite is simply unimaginable to most parents. But that is the sad reality for many families each day," USAID Administrator Rajiv Shah writes in a Huffington Post Blog opinion piece, noting, "Last year over seven million children under five died of largely preventable causes."
Genomic Health, Inc. today announced positive preliminary results from a study of Oncotype DX in patients with DCIS by the Eastern Cooperative Oncology Group, a clinical trials cooperative group supported by the National Cancer Institute.
Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has announced that a patient, who wishes to remain anonymous, donated the majority of the funds necessary for Christus St. Vincent Medical Center, Santa Fe, NM, to purchase a SonicOne(R) Ultrasonic Wound Cleansing and Debridement System. The System was shipped and installed during the second half of August 2009.
Migraine sufferers who experienced abuse and neglect as children have a greater risk of cardiovascular (CV) disease including stroke and myocardial infarction (MI) among others, say scientists presenting data at the American Headache Society's 52nd Annual Scientific Meeting in Los Angeles this week.
› Verified 5 days ago
| Provider Name | Interventional Partners Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1750814737 PECOS PAC ID: 6800173204 Enrollment ID: O20170512002018 |
News Archive
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the Food and Drug Administration (FDA) has accepted for filing and designated for Priority Review the Company's New Drug Application (NDA) for rifaximin tablets 550 mg for the maintenance of remission of hepatic encephalopathy (HE). Additionally, the FDA has informed the Company of its plan to schedule an Advisory Committee meeting in late February 2010 to discuss the application.
"Seeing a child die from pneumonia, diarrhea or a mosquito bite is simply unimaginable to most parents. But that is the sad reality for many families each day," USAID Administrator Rajiv Shah writes in a Huffington Post Blog opinion piece, noting, "Last year over seven million children under five died of largely preventable causes."
Genomic Health, Inc. today announced positive preliminary results from a study of Oncotype DX in patients with DCIS by the Eastern Cooperative Oncology Group, a clinical trials cooperative group supported by the National Cancer Institute.
Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has announced that a patient, who wishes to remain anonymous, donated the majority of the funds necessary for Christus St. Vincent Medical Center, Santa Fe, NM, to purchase a SonicOne(R) Ultrasonic Wound Cleansing and Debridement System. The System was shipped and installed during the second half of August 2009.
Migraine sufferers who experienced abuse and neglect as children have a greater risk of cardiovascular (CV) disease including stroke and myocardial infarction (MI) among others, say scientists presenting data at the American Headache Society's 52nd Annual Scientific Meeting in Los Angeles this week.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Birau, DPM 8135 Forest Ln # 515057, Dallas, TX 75230-2472 Ph: () - | Michael Birau, DPM 1601 N Belt Line Rd Ste A, Mesquite, TX 75149-1791 Ph: (972) 288-7441 |
News Archive
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the Food and Drug Administration (FDA) has accepted for filing and designated for Priority Review the Company's New Drug Application (NDA) for rifaximin tablets 550 mg for the maintenance of remission of hepatic encephalopathy (HE). Additionally, the FDA has informed the Company of its plan to schedule an Advisory Committee meeting in late February 2010 to discuss the application.
"Seeing a child die from pneumonia, diarrhea or a mosquito bite is simply unimaginable to most parents. But that is the sad reality for many families each day," USAID Administrator Rajiv Shah writes in a Huffington Post Blog opinion piece, noting, "Last year over seven million children under five died of largely preventable causes."
Genomic Health, Inc. today announced positive preliminary results from a study of Oncotype DX in patients with DCIS by the Eastern Cooperative Oncology Group, a clinical trials cooperative group supported by the National Cancer Institute.
Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has announced that a patient, who wishes to remain anonymous, donated the majority of the funds necessary for Christus St. Vincent Medical Center, Santa Fe, NM, to purchase a SonicOne(R) Ultrasonic Wound Cleansing and Debridement System. The System was shipped and installed during the second half of August 2009.
Migraine sufferers who experienced abuse and neglect as children have a greater risk of cardiovascular (CV) disease including stroke and myocardial infarction (MI) among others, say scientists presenting data at the American Headache Society's 52nd Annual Scientific Meeting in Los Angeles this week.
› Verified 5 days ago
Rebekah Cherian, D.P.M. Podiatrist Medicare: Medicare Enrolled Practice Location: 1601 N Belt Line Rd Ste A, Mesquite, TX 75149 Phone: 972-288-7442 | |
Dr. William C Arrington Ii, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1601 N Belt Line Rd, Suite A, Mesquite, TX 75149 Phone: 972-288-7441 Fax: 972-289-8025 | |
Interventional Partners Pllc Podiatrist Medicare: Medicare Enrolled Practice Location: 1601 N Belt Line Rd Ste A, Mesquite, TX 75149 Phone: 972-288-7441 Fax: 972-289-8025 | |
Robert A. Young Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1336 N Galloway Ave, Suite 124, Mesquite, TX 75149 Phone: 972-288-7441 Fax: 972-289-8025 | |
Motion Foot & Ankle Institute Podiatrist Medicare: Medicare Enrolled Practice Location: 1320 N Galloway Ave Ste 105, Mesquite, TX 75149 Phone: 214-550-2099 Fax: 214-550-2099 | |
Michael Jan Miller, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1675 Republic Pkwy, Suite 101, Mesquite, TX 75150 Phone: 972-270-7627 Fax: 972-270-7759 |